Navigation Links
Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP)
Date:4/9/2012

COCONUT GROVE, Fla., April 9, 2012 /PRNewswire/ --Med-Tek a developer of Healthcare Technology Networks ("HTN") designed to improve outcomes for patients, physicians, employers and their constituents today announces the launch of its proprietary Opioid Management Program (OMP).

According to the United States Bone & Joint Decade, from 2002 through 2004 individuals suffering from musculoskeletal disease filled 1.6 billion prescriptions. While 18.6 is the mean number of prescriptions filled per person, 83.5% of sufferers only filled a single prescription.(1) These staggering figures combined with often publicized concerns including lethal overdose, addiction, elongated claim durations and ever-increasing costs, has driven the workers' compensation industry to seek out more effective means to manage opioid dosing practices.

Tom B. Leamon, Ph.D., Med-Tek Board Member and former Vice President, Director of the Liberty Mutual Research Institute for Safety stated "given the amount of research on the magnitude of the issues associated with opioid abuse in the occupational and non-occupational settings, an evidence-based solution directly impacting the root of the problem is far overdue".

When diagnosing and treating Soft Tissue Injuries (STIs) - including dispensing of opioids - practitioners in both the work and non-work arenas have not historically been afforded benefits generated by scientifically validated data. With OMP, in addition to corroborating subjective patient complaints, the existence of acute pathology can be quantified.

"Medical professionals with OMP in their arsenal will have access to empirical data augmenting their clinical expertise. Furthermore, yielding even better results, care management tools employed by carriers, Pharmacy Benefit Managers (PBMs), Third Party Administrators (TPAs) as well as managed care providers can be applied in the right instances and at the right time" said Kerwi
'/>"/>

SOURCE Med-Tek, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2013 through 2020. Also, a ...
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report ... Animals. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:9/16/2014)... , Sept. 16, 2014  ROX Medical ... an international multi-center, prospective, randomized, controlled, blinded endpoint ... of arterial hypertension. The CONTROL-HTN trial, NCT01642498, evaluated the ... a fixed connection between a central artery and ... treatment of hypertension. The primary outcomes are reduction ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11
(Date:9/16/2014)... 16, 2014 (HealthDay News) -- Although magnesium sulfate is ... preterm delivery, new research suggests it won,t provide any ... effects of magnesium sulfate given to pregnant women, researchers ... behavioral, growth or functional outcomes among those children when ... old. The new findings don,t negate the fact ...
(Date:9/16/2014)... as part of breast conservation is the current ... (HR+) invasive breast cancer. A new study by ... that combination may not be necessary for all ... results, which Fox Chase researchers presented at the ... on Sunday, September 14, suggest that low-risk patients ...
(Date:9/16/2014)... DC (PRWEB) September 16, 2014 Programs ... potentially yield hundreds of billions of dollars in savings ... report by the Commonwealth Fund. To help spur these ... seeking up to 10 collaborative groups from across the ... 1.0 ( http://bit.ly/1wo4gsa ) - a handbook designed to ...
(Date:9/16/2014)... Silver Spring, Md. (PRWEB) September 16, 2014 ... University of Colorado Anschutz Medical Campus and Children’s ... 2014. PHA is the country’s leading pulmonary hypertension association ... hypertension (PH) – a disease of the lungs that affects ... heart failure. Without treatment, mean survivability is only 2.8 years. ...
(Date:9/16/2014)... HealthDay Reporter TUESDAY, Sept. 16, 2014 ... objective scientific way to diagnose major depression in adults, a ... nine genetic indicators (known as "RNA markers") in the blood. ... cognitive behavioral therapy, one of the most common and effective ... Northwestern University researchers report. Depression affects nearly 7 percent ...
Breaking Medicine News(10 mins):Health News:Researchers Don't See Long-Term Benefits From Drug for Preemies 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3Health News:NQF Seeks Field Testing Groups for Population Health Guide 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 3Health News:Help Fight Pulmonary Hypertension at the Colorado PH in the Park 2014 2Health News:Blood Test Spots Adult Depression: Study 2Health News:Blood Test Spots Adult Depression: Study 3
... , ARLINGTON, Va., Sept. 3 ... Services Office of Inspector General (OIG) ignored the substantial costs ... to seniors and people with disabilities who require mobility assistance. ... Supplier Acquisition Costs and Services" and dated August 2009. , ...
... , AARP Brings the Health Reform Facts ... Minn., Sept. 3 Grab your corn kernels and get ready to cast ... you to take part in the national health reform debate right here at ... lower healthcare costs, make health care more accessible, improve Medicare or lower prescription ...
... rate seems no higher than with seasonal flu , ... have died of complications from the H1N1 swine flu ... least 36 children younger than 18, a new government ... who died had at least one chronic high-risk "neurodevelopmental ...
... costs, study says , THURSDAY, Sept. 3 ... system are more likely to postpone treatment, potentially hurting ... a new study suggests. , Researchers surveyed 401 Baltimore ... attitudes toward the health care system, including doctors, hospitals ...
... 3 Reportlinker.com announces that a new market research report is ... Liver Disease Treatments: The Global Market , ... , , This Report: , ... liver disease treatments, with market forecasts through 2014 , , ...
... As millions of teens head back to school, many will be ... Teens are at a greater risk of than any other age group ... Many of those crashes could be avoided with proper education, says The ... education programs. , , NRSF spokesperson David Reich said ...
Cached Medicine News:Health News:Federal Study on Power Wheelchair Costs in Medicare Is Misleading and Ignores Costs of Required Services for Beneficiaries 2Health News:Federal Study on Power Wheelchair Costs in Medicare Is Misleading and Ignores Costs of Required Services for Beneficiaries 3Health News:Visit AARP's 'Kernels for Healthcare Reform' and Cast Your Vote 2Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 2Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 3Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 4Health News:Mistrust May Cause People to Put Off Treatment 2Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 2Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 3Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 4Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 5Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 6Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 7Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 8Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 9Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 10Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 11Health News:Reportlinker Adds Liver Disease Treatments: The Global Market Report 12Health News:Back to School Brings Risks to Young Drivers; Traffic Crashes Leading Cause of Teen Death, Says National Road Safety Foundation 2
... Reticulocyte Stain is an aqueous ... use in manual methods of ... has a one year shelf ... and can be used in ...
... Liquichek ToRCH Plus IgM Controls ... problems in your ToRCH IgM ... your test results. Liquichek ToRCH ... perfect complement to Liquichek ToRCH ...
... Plus Control is a bilevel ... the performance of the most ... assays. A weak positive and ... to monitor the performance of ...
Liquichek Unassayed Chemistry Control (Human) is a comprehensive, stable, liquid product designed to monitor general and special chemistry tests....
Medicine Products: